Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases
Dr. Christopher Austin, a National Institute of Health Director for Transitional Sciences, spoke at last year’s virtual conference honoring Rare Disease Day. According to an article in the NIH Record, Dr.…